360 High-Risk Vulnerability Immunization Tool V2.0 vs Malwarebytes Browser Guard: Features, Integrations, Reviews (2026)

360 High-Risk Vulnerability Immunization Tool V2.0 vs Malwarebytes Browser Guard: Features, Integrations, Reviews (2026) | CybersecTools

Short answer

Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats. Individual users and small teams who want browser-native protection against phishing, skimmers, and malicious ads will find Malwarebytes Browser Guard's free model hard to beat; it blocks threats before they reach your system rather than after infection, which matters when you lack dedicated endpoint detection staff. The extension stops credit card skimmers at the browser level and catches phishing attempts that slip past email filters, addressing NIST Protect controls that most free tools ignore. Skip this if you need centralized policy enforcement across hundreds of devices or integration with a broader endpoint platform; this is point protection for individuals who know their own browsing habits are the weakest link.

Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:

360 High-Risk Vulnerability Immunization Tool V2.0

Malwarebytes Browser Guard

Individual users and small teams who want browser-native protection against phishing, skimmers, and malicious ads will find Malwarebytes Browser Guard's free model hard to beat; it blocks threats before they reach your system rather than after infection, which matters when you lack dedicated endpoint detection staff. The extension stops credit card skimmers at the browser level and catches phishing attempts that slip past email filters, addressing NIST Protect controls that most free tools ignore. Skip this if you need centralized policy enforcement across hundreds of devices or integration with a broader endpoint platform; this is point protection for individuals who know their own browsing habits are the weakest link.

360 High-Risk Vulnerability Immunization Tool V2.0 vs Malwarebytes Browser Guard FAQ

Common questions about comparing 360 High-Risk Vulnerability Immunization Tool V2.0 vs Malwarebytes Browser Guard for your endpoint protection platform needs.

What is the difference between 360 High-Risk Vulnerability Immunization Tool V2.0 and Malwarebytes Browser Guard?

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Malwarebytes Browser Guard: Browser extension blocking ads, trackers, malware, phishing & scams. built by Malwarebytes. Core capabilities include Malicious website blocking, Phishing attempt prevention, Credit card skimmer protection..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

What features do 360 High-Risk Vulnerability Immunization Tool V2.0 and Malwarebytes Browser Guard offer?

Who makes 360 High-Risk Vulnerability Immunization Tool V2.0 and Malwarebytes Browser Guard?

Is 360 High-Risk Vulnerability Immunization Tool V2.0 a good alternative to Malwarebytes Browser Guard?

Have more questions? Browse our categories or search for specific tools.

360 High-Risk Vulnerability Immunization Tool V2.0 vs Malwarebytes Browser Guard: Side-by-Side Comparison (2026)

Short answer